CorMedix to acquire nearly all of Heron Therapeutics' assets in cash-and-stock dealNov 9M&ACorMedix Inc.Heron Therapeutics, Inc. /De/Updated
Bicara reaches substantial enrollment in HPV-negative head and neck cancer trialNov 9Quarterly updateBicara TherapeuticsCompass Therapeutics
Sign inSign in